The replacement of azathioprine by mycophenolate mofetil in pediatric patients with specific risks in renal transplantation

Transplantation Proceedings

Volumn 31, Issue 6, 1999, Pages 2279-

  Anguita, A ^a   Repetto, H A ^a   Rodriguez Rilo, L ^a   Vazquez, L A ^a   Iturzaeta, A ^a   Morrone, G ^a   Deheza, R ^a   Maldonado, L ^a   Goldberg, J L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADOLESCENT; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HIGH RISK PATIENT; HUMAN; KIDNEY DISEASE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; PEDIATRICS; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; AZATHIOPRINE; CHILD; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MYCOPHENOLIC ACID; PATIENT SELECTION; RISK FACTORS;

EID: 0345493786     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(99)00337-1     Document Type: Conference Paper

References (3)

1. Ransom J.T. Ther Drug Monit. 17:1995;681.
2. Sollinger H.W. Transplantation. 60:1995;225.
3. Lancet. 345:1995;1321.